Raymond James Financial
GH icon

Raymond James Financial’s Guardant Health GH Stock Holding History

Raymond James Financial’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30M Buy
338,389
+9,757
+3% +$980K 0.01% 1193
2025
Q4 		$33.2M Sell
328,632
-1,261
-0.4% -$113K 0.01% 1091
2025
Q3 		$20.6M Buy
329,893
+97,294
+42% +$5.29M 0.01% 1392
2025
Q2 		$12.1M Buy
232,599
+169,110
+266% +$7.55M ﹤0.01% 1729
2025
Q1 		$2.7M Sell
63,489
-8,875
-12% -$383K ﹤0.01% 2777
2024
Q4 		$2.21M Buy
+72,364
New +$2.04M ﹤0.01% 2893

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's GH Position: Q1 2026 in Review

Raymond James Financial increased its Guardant Health (GH) stake by 3% in Q1 2026, buying an estimated $980K and bringing the position to 338,389 shares worth $30M. The position accounts for 0.01% of the portfolio, ranked #1193.

Raymond James Financial first reported a position in GH in Q4 2024 and has held it in 6 quarters since. The position peaked at $33.2M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Raymond James Financial held 338,389 shares of Guardant Health worth $30M as of Q1 2026.
  • Raymond James Financial bought 9,757 Guardant Health shares in Q1 2026, an estimated $980K.
  • Guardant Health made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1193 holding.
  • Raymond James Financial first reported a position in Guardant Health in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's Guardant Health position peaked at $33.2M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.